Hutchmed (china) Ltd balance sheet

At the end of fiscal 2025, Hutchmed (china) Ltd had total assets of $1.75bn, total liabilities of $502m and shareholders' equity of $1.24bn. It held $71.3m in cash against $118m of debt: net debt of $46.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Hutchmed (china) Ltd: balance sheet, annual
Fiscal year	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	39	32	79	85	86	121	236	378	313	284	154	71
Receivables	—	33	41	38	40	41	48	84	98	117	156	127
Inventory	—	10	13	12	12	16	20	36	57	50	50	41
Total current assets	—	90	167	432	371	317	531	1,212	840	1,097	1,067	1,567
Goodwill	3	3	3	3	3	3	3	3	3	3	3	3
Total assets	—	230	342	598	532	465	724	1,373	1,029	1,280	1,274	1,753
Accounts payable	—	21	36	24	26	24	32	41	71	36	43	46
Deferred revenue (current)	—	1	1	1	3	2	2	12	13	58	50	31
Total current liabilities	—	81	95	105	85	113	158	312	354	403	377	316
Short-term debt	—	—	20	30	—	—	—	27	—	31	23	25
Long-term debt	—	27	27	30	27	27	27	—	18	48	59	68
Total debt	0	73	67	30	27	27	27	27	18	110	106	118
Total liabilities	—	127	138	113	120	152	205	333	393	536	502	502
Shareholders' equity	57	83	184	462	389	288	484	987	610	731	760	1,238
Non-controlling interests and other (assets − liabilities − equity)	—	19	20	23	23	25	35	53	27	—	—	—
Net debt (negative = net cash)	−39	41	−13	−55	−59	−94	−209	−351	−295	−173	−48	47

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ADMA vs HCM HCM vs TARS HCM vs MIRM

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Hutchmed (china) Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Hutchmed (china) Ltd.